About motus gi holdings inc - MOTS
Motus GI Holdings, Inc. is a medical technology company, which is dedicated to improving endoscopy outcomes and experiences. It engages in the development and commercialization of the Pure-Vu System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon. The company was founded in 2008 and is headquartered in Fort Lauderdale, FL.
MOTS At a Glance
Motus GI Holdings, Inc.
1301 East Broward Boulevard
Fort Lauderdale, Florida 33301
| Phone | 1-954-541-8000 | Revenue | 319.00K | |
| Industry | Medical Specialties | Net Income | -12,867,000.00 | |
| Sector | Health Technology | Employees | 15 | |
| Fiscal Year-end | 12 / 2024 | |||
| View SEC Filings |
MOTS Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 3.235 |
| Price to Book Ratio | 0.734 |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | 0.13 |
| Enterprise Value to Sales | -4.57 |
| Total Debt to Enterprise Value | -1.693 |
MOTS Efficiency
| Revenue/Employee | 21,266.667 |
| Income Per Employee | -857,800.00 |
| Receivables Turnover | 4.197 |
| Total Asset Turnover | 0.026 |
MOTS Liquidity
| Current Ratio | 1.761 |
| Quick Ratio | 1.686 |
| Cash Ratio | 1.516 |
MOTS Profitability
| Gross Margin | -184.483 |
| Operating Margin | -3,732.602 |
| Pretax Margin | -4,033.542 |
| Net Margin | -4,033.542 |
| Return on Assets | -103.474 |
| Return on Equity | -454.343 |
| Return on Total Capital | -249.602 |
| Return on Invested Capital | -165.078 |
MOTS Capital Structure
| Total Debt to Total Equity | 91.85 |
| Total Debt to Total Capital | 47.876 |
| Total Debt to Total Assets | 34.169 |
| Long-Term Debt to Equity | 47.116 |
| Long-Term Debt to Total Capital | 24.559 |